Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
8.25M
-
Shares change
-
-360K
-
Total reported value, excl. options
-
$90.2M
-
Value change
-
-$4.84M
-
Number of buys
-
15
-
Number of sells
-
-21
-
Price
-
$10.93
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2020
49 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2020.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.25M shares
of 92.4M outstanding shares and own 8.92% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.41M shares), ORBIMED ADVISORS LLC (1.48M shares), BlackRock Inc. (729K shares), FMR LLC (636K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (470K shares), Fosun International Ltd (324K shares), STATE STREET CORP (235K shares), GEODE CAPITAL MANAGEMENT, LLC (180K shares), NORTHERN TRUST CORP (152K shares), and Steel Peak Wealth Management LLC (132K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.